• Main
• Products
  • Diabetes Equipments
  • View by Condition
  • For Tube Feeding
• Articles
  • Diabetes Care
  • Cancer Care
  • Wound Care
• Ask The Experts
  • Diabetes
  • Cancer
• Events
• Your Say

Jevity^® Powder

Specialised Feed

The advantages of Jevity^® in a cost effective and convenient powder

Complete & balanced nutrition to help improve patient nutrition status

• Meets Institute of Medicine guidelines for ratio of protein, fats and carbohydrates in a healthy adult diet ²
• Meets American Heart Association dietary guidelines for healthy adults by providing only 30% of calories from fat ³

Patented mixed-fiber/FOS system helps improve GI tolerance

• System blends soluble (soy polysaccharide and oat fiber) and insoluble fibers (gum arabic, carboxymethyl cellulose and gellan gum), which can help manage both mild-to-moderate constipation ⁴ and diarrhoea ^{5, 6}
• Fructooligosaccharides (FOS) stimulate absorption of water and electrolytes in the colon,^{5, 6} actions important for diarrhoea management ⁷

Therapeutic levels of FOS (recommended at 10 g/day) help maintain a healthy immune system and inhibit growth of Clostridium difficile bacteria in patients at risk

• FOS, a prebiotic that promotes the growth of beneficial bacteria (e.g. bifidobacteria) in the colon,⁸ which helps maintain gastrointestinal tract integrity and immune function ^{9, 10}
• Colonic bacteria ferment FOS to short-chain fatty acids, which acidify the colon and create an unfavorable environment for growth of Clostridium difficile, an intestinal pathogen ¹¹

Easy to use, transport, and store

• Mixes at 0.5, 0.75 and 1.0 cal/ml concentrations to help initiate tube
• feeding in patients
• Easier to store and transport than liquid feeds

References

1. Abbott Laboratories. Institutional Nutrition Tracking Study. Data collected January through June 2008; 2008.
2. Institute of Medicine. http://www.iom.edu/board.asp?id=3788. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). 2005.
3. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee. J Am Heart Assoc. 2006;114:82-96.
4. Swennen K, Courtin C, Delcour J. Non-digestible oligosaccharides with prebiotic properties. Crit Rev Food Sci and Nutr. 2006;46:459-471.
5. Bowling T, Raimundo A, Grimble G, Silk D. Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet. 1993;342:1266-1268.
6. Roberfroid M, Van Loo J, Gibson G. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998;128:11-19.
7. Bartlett J. Antibiotic-associated diarrhoea. Infections of the Gastrointestinal Tract. New York: Raven Press; 1995:893-904.
8. Bouhnik Y, Raskine L, Simoneau G, Paineau D, Bornet F. The capacity of short-chain fructooligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutr J. 2006;5:8.
9. Gibson G, Roberfroid M. Dietary modulation of the human colonic microbiota—introducing the concept of prebiotics. J Nutr. 1995;125:1401-1412.
10. Hosono A, Ozawa A, Kato R, Ohnishi Y, Nakanishi Y, Kimura T. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer’s patch cells. Biosci Biotechnol Biochem. 2003;67:758-764.
11. May T, Mackie R, Fahley GJ, Cremin J, Garleb K. Effect of fiber sources on short-chain fatty acid production and on the growth an toxin production by Clostridium difficile. Scand J Gastroenterol. 1994;29:916-922.

AMP030309

Back to top